Cargando…
FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
SIMPLE SUMMARY: In the present review the authors report the predictive value of FDG/PET-CT (PET) on treatment outcome of Hodgkin lymphoma patients showing a post-chemotherapy residual mass, based on the published reports of PET-guided consolidation radiotherapy after different-intensity chemotherap...
Autores principales: | Gallamini, Andrea, Kurlapski, Michał, Zaucha, Jan Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391562/ https://www.ncbi.nlm.nih.gov/pubmed/34439108 http://dx.doi.org/10.3390/cancers13163952 |
Ejemplares similares
-
Initial Staging of Hodgkin’s Disease: Role of Contrast-Enhanced (18)F FDG PET/CT
por: Chiaravalloti, Agostino, et al.
Publicado: (2014) -
FDG-PET Scan: a new Paradigm for Follicular Lymphoma Management
por: Gallamini, Andrea, et al.
Publicado: (2017) -
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022) -
The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017) -
Occipital Hypometabolism on FDG PET/CT Scan in a Child with Hodgkin's Lymphoma
por: Uslu Biner, Inci, et al.
Publicado: (2016)